deltatrials
Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07034807

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2

Evidence-based Evaluation of Yiqi Jiangzhuo Huoxue Tongluo Method in Delaying the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study 2

Sponsor: EFONG PHARMRCEUTICRL

Conditions Diabetic Kidney Disease (DKD)
Interventions basic treatment the traditional Chinese medicine prescription ' Shenzhuo Decoction '
Updated 1 time since 2025 Last updated: Jun 20, 2025 Started: Aug 1, 2025 Primary completion: Jul 31, 2028 Completion: Jul 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07034807, this NA trial focuses on Diabetic Kidney Disease (DKD) and remains actively recruiting participants. Sponsored by EFONG PHARMRCEUTICRL, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jul 2025 – present · 12 months · monthly snapshotNot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • EFONG PHARMRCEUTICRL
  • First Affiliated Hospital, Sun Yat-Sen University
  • Guang'anmen Hospital，China Academy of Chinese Medical Sciencescancel
  • Liu Hongfang
  • The Affiliated Hospital to ChangChun University of Chinese Medicinecancel
  • Tianjin Medical University Chu Hsien-I Memorial Hospital
Data source: Dongzhimen Hospital, Beijing

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations